Last call for injectable opiate maintenance: In pursuit of an evidence base for good clinical practice

Heroin Addiction and The British System

Volumn 2, Issue , 2004, Pages 119-128

  Zador, Deborah ^a,b,c  

^a ROYAL AUSTRALASIAN COLLEGE OF PHYSICIANS   (Australia)

^b Australasian Faculty of Public Health Medicine   (Australia)

^c Network of Addiction services   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84909249413     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203643358     Document Type: Chapter

References (28)

1. Advisory Council on Misuse of Drugs (2000). Reducing drug related deaths. The Stationery Office, London.
2. Battersby, M., Farrell, M., Gossop, M., Robson, P. and Strang, J. (1992). 'Horse trading': prescribing injectable opiates to opiate addicts. A descriptive study. Drug and Alcohol Review, 11, 35-42.
3. Coomber, R. (1997). The adulteration of drugs: what dealers do to illicit drugs and what they think is done to them. Addiction Research, 5, 297-306.
4. Darke, S. and Zador, D. (1996). Fatal heroin 'overdose': a review. Addiction, 91, 1765-1772.
5. Darke, S., Hall, W., Weatherburn, D. and Lind, B. (1999). Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug and Alcohol Dependence, 54, 155-161.
6. Edwards, G. (1969). The British approach to the treatment of heroin addiction. The Lancet, i, 768-772.
7. Edwards, G. (1979). British policies on opiate addiction: ten years working of the revised response and options for the future. British Journal of Psychiatry, 134, 1-13.
8. Hall, W. (1999). Assessing the population-level impact of the Swiss model of heroin prescribing. Technical Report Number 76, National Drug and Alcohol Research Centre, Sydney.
9. Hartnoll, R.L., Mitcheson, M.C., Battersby, A., Brown, G., Ellis, M., Fleming, B.M. and Hedley, M.B. (1980). Evaluation of heroin maintenance in controlled trial. Archives of General Psychiatry, 37, 877-884.
10. House of Commons (2002). Home Affairs Select Committee. Hansard.
11. McCusker, C. and Davies, M. (1996). Prescribing drug of choice to illicit heroin users: the experience of a UK community drug team. Journal of Substance Abuse Treatment, 13, 521-531.
12. Metrebian, N., Shanahan, W. and Stimson, G.V. (1996). Heroin prescribing in the United Kingdom: an overview. European Addiction Research, 2, 194-200.
13. Metrebian, N., Shanahan, W., Wells, B. and Stimson, G.V. (1998). Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Medical Journal of Australia, 168, 596-600.
14. Metrebian, N., Carnwath, T., Stimson, G. and Storz, T. (2002). Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction, 97, 1155-1161.
15. Perneger, T.V., Giner, F., del Rio, M. and Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. British Medical Journal, 317, 13-18.
16. Powis, B., Strang, J., Griffiths, P., Taylor, C., Williamson, S., Fountain, J. and Gossop, M. (1999). Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction, 94, 471-478.
17. Risser, D., Uhl, A., Stichenwirth, M., Honigschnabl, S., Hirz, W., Schneider, B., Stellwag-Carion, C., Klupp, N., Vycudilik, W. and Bauer, G. (2000). Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria. Addiction, 95, 375-382.
18. Sell, L., Farrell, M. and Robson, P. (1997). Prescription of diamorphine, dipipanone and cocaine in England and Wales. Drug and Alcohol Review, 16, 221-226.
19. Strang, J. and Gossop, M. (1994). Heroin Addiction and Drug Policy: The British System. Oxford University Press, Oxford.
20. Strang, J. and Sheridan, J. (1998). Effect of government recommendations on methadone prescribing in south east England: comparison of 1995 and 1997 surveys. British Medical Journal 317, 1489-1490.
21. Strang, J. and Sheridan, J. (2002). Injectable methadone prescribing: a peculiarly British treatment. In Tober, G. and Strang, J. (eds) Methadone Matters. Dunitz, London.
22. Strang, J. and Sheridan, J. (2003). Effect of national guidelines on prescription of methadone: analysis of NHS prescription data, England 1990-2001. British Medical Journal 327, 321-322.
23. Strang, J., Marsden, J., Cummins, M. et al. (2000). Randomised trial of supervised injectable versus oral methadone maintenance: report on feasibility and six-month outcome. Addiction, 95, 1631-1645.
24. Strang, J., Sheridan, J. and Barber, N. (1996). Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. British Medical Journal, 313, 270-272.
25. Swift, W., Maher, L. and Dawson, M. (1999). Heroin purity and composition: an analysis of street-level samples in Cabramatta, New South Wales. Technical Report Number 79. National Drug and Alcohol Centre, Sydney.
26. Thorley, A., Oppenheimer, E. and Stimson, G.V. (1977). Clinic attendance and opiate prescription status of heroin addicts over a six-year period. British Journal of Psychiatry, 130, 565-569.
27. Uchtenhagen, A. (1997). Summary of the synthesis report. In Uchtenhagen, A., Gutzwiller, F. and Dobler-Mikola, A. (eds) Programme for a Medical Prescription of Narcotics. Final Report of the Research Representatives (pp. 1-11). Zurich Institute for Social and Preventive Medicine, University of Zurich.
28. UK Department of Health (1999). Drug misuse and dependence-guidelines on clinical management. The Stationery Office, London.